ES2058072T3 - Uso vaginal topico de p-isobutilfenilpropionato de lisina en tratamiento anti-inflamatorio. - Google Patents

Uso vaginal topico de p-isobutilfenilpropionato de lisina en tratamiento anti-inflamatorio.

Info

Publication number
ES2058072T3
ES2058072T3 ES87106201T ES87106201T ES2058072T3 ES 2058072 T3 ES2058072 T3 ES 2058072T3 ES 87106201 T ES87106201 T ES 87106201T ES 87106201 T ES87106201 T ES 87106201T ES 2058072 T3 ES2058072 T3 ES 2058072T3
Authority
ES
Spain
Prior art keywords
lysine
isobutylphenylpropionate
treatment
vaginal
inflammatory treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87106201T
Other languages
English (en)
Inventor
Giorgio Zagnoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lisapharma SpA
Original Assignee
Lisapharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisapharma SpA filed Critical Lisapharma SpA
Application granted granted Critical
Publication of ES2058072T3 publication Critical patent/ES2058072T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION DESCRIBE EL USO TOPICO VAGINAL DE P-FENILPROPIONATO DE LISINA EN UN TRATAMIENTO LOCAL Y DIRIGIDO DE PATOLOGIAS DE TIPO OBSTETRICO Y GINECOLOGICO. DICHO USO ES EFICAZ EN EL TRATAMIENTO QUE PACIENTES CON FORMAS DE ETIOLOGIA ESPECIFICA O NO ESPECIFICA, Y TAMBIEN EN EL TRATAMIENTO TANTO DE PACIENTES QUE DEPENDEN DE LA MEDICINA COMO DE LA CIRUGIA. EL P-ISOBUTILFENILPROPIONATO DE LISINA SE USA EN FORMA DE SOLUCION ACUOSA PARA LAVADOS VAGINALES O EN OTRAS FOMAS FARMACEUTICAS PARA EL USO VAGINAL TALES COMO GLOBULOS, SUPOSITORIOS, ETC....
ES87106201T 1986-06-16 1987-04-29 Uso vaginal topico de p-isobutilfenilpropionato de lisina en tratamiento anti-inflamatorio. Expired - Lifetime ES2058072T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20797/86A IT1190348B (it) 1986-06-16 1986-06-16 Impiego topico vaginale del p-isobutilfenilpropionato di lisina nel trattamento antiinfiammatorio

Publications (1)

Publication Number Publication Date
ES2058072T3 true ES2058072T3 (es) 1994-11-01

Family

ID=11172205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87106201T Expired - Lifetime ES2058072T3 (es) 1986-06-16 1987-04-29 Uso vaginal topico de p-isobutilfenilpropionato de lisina en tratamiento anti-inflamatorio.

Country Status (8)

Country Link
US (1) US4755533A (es)
EP (1) EP0253083B1 (es)
JP (1) JPS62298527A (es)
AT (1) ATE110566T1 (es)
CA (1) CA1288332C (es)
DE (1) DE3750447T2 (es)
ES (1) ES2058072T3 (es)
IT (1) IT1190348B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
WO1996023490A1 (en) * 1995-02-03 1996-08-08 Cosmederm Technologies Formulations and methods for reducing skin irritation
KR100206660B1 (ko) * 1996-08-13 1999-07-01 이종훈 열교환기 전열면의 부착물 감시장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica

Also Published As

Publication number Publication date
JPS62298527A (ja) 1987-12-25
IT1190348B (it) 1988-02-16
ATE110566T1 (de) 1994-09-15
DE3750447D1 (de) 1994-10-06
EP0253083A3 (en) 1990-05-16
EP0253083B1 (en) 1994-08-31
IT8620797A1 (it) 1987-12-16
CA1288332C (en) 1991-09-03
DE3750447T2 (de) 1995-01-26
EP0253083A2 (en) 1988-01-20
IT8620797A0 (it) 1986-06-16
US4755533A (en) 1988-07-05

Similar Documents

Publication Publication Date Title
ES551441A0 (es) Procedimiento para el tratamiento de formas de dosificacion farmaceuticas
SE7903431L (sv) Bandage
BR9406746A (pt) Composto processo para sua preparaçao preparado farmacêutico uso de um composto processo para a obtençao da inibiçao de trombina em um organismo humano ou animale fragmento estrutural
DK135305B (da) N-substituerede-p-menthan-3-carboxamider til anvendelse som middel til fremkaldning af en fysiologisk kuldeeffekt på huden eller slimhinderne af det menneskelige legeme.
ATE71288T1 (de) Mischmicell-loesungen mit nichtsteroidalen entzuendungshemmern.
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
ES2027763T3 (es) Cemento oseo para la liberacion controlada de sustancias.
ES2063841T3 (es) Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
ES2058072T3 (es) Uso vaginal topico de p-isobutilfenilpropionato de lisina en tratamiento anti-inflamatorio.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
ES2184880T3 (es) Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.
BR9908716A (pt) Tratamento de disfunção sexual em certos grupos de pacientes
ES2090167T3 (es) Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.
AR029189A1 (es) Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ES2151922T3 (es) Uso de aspirina para la fabricacion de un medicamento para mejorar la perfusion sanguinea en el utero.
ES2135065T3 (es) Derivados de amida y su uso terapeutico.
ES511730A0 (es) "un procedimiento para la preparacion de oxaprocin calcico".
BR9814136A (pt) Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto.
SE8802040D0 (sv) New use
FI952018A (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
ATE45674T1 (de) Kombinationspraeparat.
FR2638966B1 (fr) Douche autonome, portable, sterile, pour le lavage des parties du corps humain ou animal agressees notamment par des produits chimiques

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 253083

Country of ref document: ES